About LaCell
LaCell is a company based in New Orleans (United States) founded in 2010. LaCell operates in a competitive market with competitors including BioLife Solutions, RoosterBio, Shanghai Doning Biotechnology, Polyplus Transfection and ArunA Bio, among others.
- Headquarter New Orleans, United States
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
$225 K (USD), Grant
Jul 01, 2016
-
Investors
HHS
& 1 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of LaCell
Investors in LaCell
LaCell has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include HHS and National Science Foundation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
A government-backed foundation providing seed-stage investments to support small businesses.
|
Locked | Locked | Locked | |
|
Public health and human services are overseen by HHS.
|
Locked | Locked | Locked |
Investor details for LaCell
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by LaCell
Investment portfolio details for LaCell
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - LaCell
Detailed financials for LaCell
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Lacell Comparisons
Peer comparison for LaCell
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of LaCell
LaCell operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as BioLife Solutions, RoosterBio, Shanghai Doning Biotechnology, Polyplus Transfection and ArunA Bio, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Tissue hypothermic storage and cryopreservation freeze media are developed.
|
|
| Locked | Locked | Locked |
Developer of human mesenchymal stem cells and extracellular vesicles
|
|
| Locked | Locked | Locked |
Serum-free cell culture media is supplied to biopharmaceutical industries.
|
|
| Locked | Locked | Locked |
Transfection Solutions for Healthcare and Life Sciences organizations
|
|
| Locked | Locked | Locked |
Neural exosome platform is developed for neurodegenerative disease therapeutics.
|
|
| Locked | Locked | Locked |
Veterinary diagnostics products are developed for bovine viral diarrhea testing.
|
Detailed competitors of LaCell
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Lacell
Complete news archive for LaCell
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about LaCell
LaCell was founded in 2010 and raised its 1st funding round 2 years after it was founded.
LaCell is headquartered in New Orleans, United States. It is registered at New Orleans, Louisiana, United States.
LaCell focuses on the production of stem cells for scientific investigators in the academic and biotechnology research community. The company plans to facilitate to clinical translation and regulatory approval of stem cells as regenerative therapies. Its product portfolio includes human adult stem cell, murine stem cell, and medium saline reagents.
LaCell's top competitors include FabricNano, RoosterBio and BioLife Solutions.
LaCell has 2 investors. Key investors include HHS, and National Science Foundation.